Jade Biosciences, Inc. - 8-K Filing
Jade Biosciences entered into an underwriting agreement on June 3, 2026 to issue and sell 10 million shares of common stock at $15.00 per share (underwriters purchase price: $14.10), with a 30-day option for the underwriters to buy up to 1.5 million additional shares. The offering is expected to close on June 5, 2026 and raise approximately $140.3 million in net proceeds (or $161.5 million if the over-allotment option is exercised). (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $AVTE